AB

Apurba Bhusan Mazumder

Active Director Director DIN 10248646
DIN 10248646 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Apurba Bhusan Mazumder

Data last updated:

Apurba Bhusan Mazumder is a Director at Damizo Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Damizo Pharmaceuticals Private Limited reported revenue of ₹6.4 Lakh (FY 2024).

DIN 10248646
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2023
Oldest Company Age 3 yrs
Largest company Damizo Pharmaceuticals Private Limited · ₹6.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 20232023₹6.4 Lakh (FY 2024)Active

Board colleagues of Apurba Bhusan Mazumder

NameDINCompanyDesignation
Mohibul Jamader10248647Damizo Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Damizo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Apurba Bhusan Mazumder

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apurba Bhusan Mazumder

Apurba Bhusan Mazumder currently holds 1 directorship: Damizo Pharmaceuticals Private Limited (Director, since 21 Jul 2023, revenue ₹6.4 Lakh (FY 2024)).

Apurba Bhusan Mazumder was first appointed on 21 Jul 2023 as Director at Damizo Pharmaceuticals Private Limited.

The current boards of Apurba Bhusan Mazumder's companies include Mohibul Jamader (Damizo Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available